Anjali Kaimal, MD, MAS is an Associate Professor in the Department of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School and a Maternal-Fetal Medicine Specialist at Massachusetts General Hospital. Her research program is focused on the definition, design, execution, and dissemination of evidence-based, patient-centered interventions to improve the quality and effectiveness of obstetric care, particularly regarding mode of delivery and interventions during pregnancy including induction of labor, prenatal testing, and medications for management of medical complications. She is currently the site principal investigator for an NIH funded trial to optimize shared decision making regarding mode of delivery after cesarean. She is the program director for the Maternal-Fetal Medicine Fellowship at Massachusetts General Hospital, and a member of the American College of Obstetricians and Gynecologists Committee on Obstetric Practice Bulletins. In collaboration with faculty in the Department of Population Medicine, she is investigating interventions to optimize decision making for primary cesarean in a large community hospital system, and working to understand opportunities to improve the use of IM progesterone to reduce the risk of recurrent preterm birth.